(E)-2-(1H-Benzoimidazol-2-yl)-3-(3-nitro-phenyl)-acrylonitrile

ID: ALA114935

PubChem CID: 5286534

Max Phase: Preclinical

Molecular Formula: C16H10N4O2

Molecular Weight: 290.28

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#C/C(=C\c1cccc([N+](=O)[O-])c1)c1nc2ccccc2[nH]1

Standard InChI:  InChI=1S/C16H10N4O2/c17-10-12(8-11-4-3-5-13(9-11)20(21)22)16-18-14-6-1-2-7-15(14)19-16/h1-9H,(H,18,19)/b12-8+

Standard InChI Key:  BMVPYKZTAYDWTM-XYOKQWHBSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.6875   -1.4500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2042   -0.7875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5125   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4000   -3.5875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2042   -2.1250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9250   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5833   -1.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9250   -0.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5833   -1.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9792   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3417   -0.0125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9917   -4.3042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2250   -3.5875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7500   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1542   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3917   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9750   -1.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2958   -0.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2958   -2.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1542   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0083   -1.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0083   -1.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4 10  1  0
  5  1  1  0
  6  3  2  0
  7  2  1  0
  8  3  1  0
  9  5  1  0
 10 15  1  0
 11  8  3  0
 12  4  1  0
 13  4  2  0
 14  6  1  0
 15 14  2  0
 16 17  1  0
 17 20  2  0
 18  7  1  0
 19  9  1  0
 20 14  1  0
 21 18  2  0
 22 19  2  0
  9  7  2  0
 21 22  1  0
 10 16  2  0
M  CHG  2   4   1  12  -1
M  END

Associated Targets(Human)

SISO (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
5637 (630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KYSE-70 cell line (224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RT-4 (268 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RT-112 (346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KYSE-150 cell line (174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KYSE-520 cell line (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
YAPC (161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCLC-103H cell line (153 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DAN-G (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TERT-RPE1 (415 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 290.28Molecular Weight (Monoisotopic): 290.0804AlogP: 3.54#Rotatable Bonds: 3
Polar Surface Area: 95.61Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.53CX Basic pKa: 3.64CX LogP: 3.63CX LogD: 3.63
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.45Np Likeness Score: -1.81

References

1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ..  (2004)  Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles.,  47  (13): [PMID:15189040] [10.1021/jm0311036]

Source